AsthmaSense Prime, iSonea Ltd.'s next-generation smartphone application that serves as one's personal asthma monitor, will be previewed at the 2014 International CES(R) Jan. 7-10, 2014, in Las Vegas. AsthmaSense Prime is equipped with unprecedented features to help inform users about changing asthma risks based on symptoms, triggers, medication usage and environmental factors pollen, weather and air quality that can amplify symptoms or provoke an attack.

AsthmaSense Prime makes it easy to record objective data related to one's asthma management to share with physicians or family members. In addition, AsthmaSense Prime has the ability to automatically incorporate wheeze measurement data when used with AirSonea, the smartphone-enabled device for monitoring wheeze. Wheeze is a cardinal sign of asthma associated with airway obstruction.

Currently available in Australia and granted a CE mark for the European market, the AirSonea device is not yet available in the United States.